Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia

NCT00962715 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

BIOLOGICAL: Influenza Vaccine Trivalent Inactivated (TIV)
DRUG: Pegylated interferon (PEGrIFN-α, Pegasys)
DRUG: Interferon (IFNα, Roferon-A)

Sponsor

M.D. Anderson Cancer Center